Evidence map›Paper›PMID 33389540›Full record

ReviewMolecular biology reports2021

Unfolding Nrf2 in diabetes mellitus.

Tapan Behl, Ishnoor Kaur, Aayush Sehgal, Eshita Sharma, Arun Kumar, Madhuri Grover, Simona Bungau

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular biology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. BioImpacts : BI · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Protective Effects of Curcumin and its AnaloguesCurrent medicinal chemistry · 2024
    Review
  11. Review
  12. Biological Activities ofMolecules (Basel, Switzerland) · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Involvement of Ferroptosis in Diabetes-Induced Liver Pathology.International journal of molecular sciences · 2022
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Tapan BehlChitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India. tapanbehl31@gmail.com.ORCID http://orcid.org/0000-0003-0993-7708
Ishnoor KaurChitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India.
Aayush SehgalChitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India.
Eshita SharmaChitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India.
Arun KumarChitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India.
Madhuri GroverB.S. Anangpuria Institute of Pharmacy, Alampur, Haryana, India.
Simona BungauDepartment of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, Oradea, Romania.
Chitkara University · INUniversity of Oradea · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In spite of much awareness, diabetes mellitus continues to remain one of major reasons for mortality and morbidity rate all over the globe. Free radicals cause oxidative stress which is responsible for causing diabetes. The recent advancements in elucidation of ARE/keap1/Nrf2 pathway can help in better understanding of diabetes mellitus. Various clinical trials and animal studies have shown the promising effect of Nrf2 pathway in reversing diabetes by counteracting with the oxidative stress produced. The gene is known to dissociate from Keap1 on coming in contact with such stresses to show preventive and prognosis effect. The Nrf2 gene has been marked as a molecular player in dealing with wide intracellular as well as extracellular cellular interactions in different diseases. The regulation of this gene gives some transcription factor that contain antioxidant response elements (ARE) in their promoter region and thus are responsible for encoding certain proteins involved in regulation of metabolic and detoxifying enzymes.

Indexed as

Antioxidant Response ElementsAnimalsAntioxidantsClinical Trials as TopicCurcuminDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Diabetic NephropathiesGene Expression RegulationHumansHypoglycemic AgentsKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2Oxidative StressProtein BindingReactive Oxygen SpeciesAntioxidantsCurcuminHypoglycemic AgentsKEAP1 protein, humanKelch-Like ECH-Associated Protein 1NFE2L2 protein, humanNF-E2-Related Factor 2Reactive Oxygen SpeciesHyperglycaemiaNrf2/Keap1/ACEOxidative stressReactive oxygen speciesType II diabetes mellitus

Identifiers

PMID33389540
OpenAlexW3118530974

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.